Price Move History
- Daily moves over 5%
- 17 236 sessions, October 8, 2025 to October 8, 2026
- Largest daily move
- -9.8% close of October 10, 2025
- 1-year change
- -32.2% closing prices, October 8, 2025 to October 8, 2026
- 1-month change
- -3.3% closing prices, September 8, 2026 to October 8, 2026
Company Description
WELL Health Technologies Corp. (OTCQX: WHTCF), also listed on the Toronto Stock Exchange under the symbol WELL, is a digital healthcare company focused on empowering healthcare practitioners and their patients by using technology to improve health outcomes. According to the company, its mission is to tech‑enable healthcare providers through technologies, services, and support that help clinicians run and secure their practices while enhancing patient care.
WELL operates a comprehensive healthcare and digital platform that includes front and back‑office management software applications used by physicians. Across the United States and Canada, WELL reports that its solutions enable tens of thousands of healthcare providers and support a large network of outpatient clinics. The company states that it powers the largest owned and operated healthcare ecosystem in Canada, with hundreds of clinics providing primary care, specialized care, and diagnostic services.
Business model and operations
Based on company disclosures, WELL combines clinical operations with healthcare technology. In Canada, its clinic network includes primary care, diagnostics, allied health, specialty, and executive health clinics. These clinics deliver in‑person and technology‑enabled care, and are supported by WELL’s digital tools for scheduling, patient engagement, and practice management.
In the United States, WELL reports that its solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and mental health. Across both countries, the company emphasizes technology‑enabled clinical environments, clinic digitization, and the use of software to improve operational efficiency and patient access.
Digital platform and clinic digitization
WELL describes its platform as including front and back‑office management software applications that help physicians run and secure their practices. These applications support activities such as online patient booking, self‑check‑in, digital patient reminders, and digital management of patient consents in many of its Canadian primary care clinics. The company refers to this set of capabilities as part of its “core digitization” efforts within its clinic network.
WELL has reported high levels of digitization across primary care clinics that have been in its network for more than several months. The company links this digitization to improvements in clinic efficiency, patient access, and the ability to support higher volumes of patient visits. It also notes that tools such as AI‑enabled documentation and decision support are being deployed across its network, with the goal of further enhancing provider productivity.
Canadian Patient Services and clinic network
Within Canada, WELL highlights its Canadian Patient Services business, which encompasses its primary care and diagnostics divisions. The company has disclosed that this segment has grown through a combination of organic growth and acquisitions. It has also reported the completion of multiple clinic acquisitions in provinces such as British Columbia, and has described a pipeline of additional clinic acquisition targets across Canada.
WELL’s Canadian clinics business includes initiatives to expand patient access. The company has announced the creation of tens of thousands of new primary care patient openings across several provinces, enabled by investments in physician recruitment and digital infrastructure. It has also described efforts to optimize clinic operations and implement cost‑efficiency initiatives, supported by its digitization and modernization programs.
Technology subsidiaries and WELLSTAR
A key component of WELL’s technology strategy is its majority‑owned subsidiary WELLSTAR Technologies Corp. WELL describes WELLSTAR as a pure‑play SaaS healthcare technology company that serves healthcare providers across Canada. WELLSTAR provides technology and services that support clinic operations, digital transformation, and interoperability for healthcare providers.
According to company statements, WELLSTAR offers a suite of technology solutions used by healthcare providers, including billing and practice management systems, electronic medical records (EMRs), digital health applications, and digital health network solutions. WELL reports that WELLSTAR’s tools support many of the digital features used in WELL’s clinics, such as online booking and digital patient workflows, and that WELLSTAR’s platform is used by a substantial portion of healthcare providers in Canada.
WELL has also highlighted WELLSTAR’s growth profile, describing it as a high‑growth, profitable SaaS business with a significant base of recurring revenue. The company has disclosed that WELLSTAR has completed equity financings to support its growth and has discussed the possibility of a future public listing for WELLSTAR, while WELL intends to maintain a majority economic and voting interest.
AI‑enabled healthcare and related initiatives
WELL has reported that AI‑enabled tools are being deployed across its network. These include AI ambient scribe capabilities and AI decision support applications that assist clinicians with documentation and clinical workflows. The company has also referenced the launch of Nexus AI, an AI‑powered clinical documentation solution available across Canada through WELLSTAR.
In addition, WELL has disclosed that subsidiaries associated with its ecosystem have participated in national programs focused on interoperability and digital health innovation. These initiatives are intended to enhance data quality, care coordination, and access to standardized health information across multiple Canadian provinces.
Geographic focus
WELL is based in Canada and describes itself as operating across Canada and the United States. In Canada, it emphasizes its role in outpatient services and clinic operations, as well as its extensive provider network and clinic footprint. In the United States, the company focuses on specific clinical markets, including gastrointestinal care, women’s health, primary care, and mental health, through its technology and services.
Capital markets and growth strategy
WELL Health Technologies Corp. is publicly traded on the Toronto Stock Exchange under the symbol WELL and on the OTCQX market under the symbol WHTCF. The company has discussed a growth strategy that combines organic expansion, technology deployment, and acquisitions in both its clinical and technology businesses. It has also disclosed the use of a senior secured credit facility led by a major Canadian bank to support its acquisition pipeline and clinic investments.
WELL frequently reports on metrics such as revenue growth, adjusted EBITDA, patient visits, and clinic counts in its public communications. It has highlighted record quarterly revenues and patient visits, as well as improvements in adjusted margins, as evidence of the scalability of its operating model and the impact of its digitization programs.
How WELL Health fits within the healthcare sector
Within the broader health care and social assistance sector, WELL positions itself as a digital healthcare and outpatient services company that combines clinical operations with technology. Its activities intersect with offices of physicians and other outpatient providers, while its technology platform supports practice management, digital health workflows, and AI‑enabled tools for clinicians.
For investors researching WHTCF stock, the company’s disclosures emphasize its dual focus on operating a large Canadian outpatient clinic network and scaling a technology platform, including its majority‑owned SaaS subsidiary WELLSTAR. These elements are central to how WELL describes its business model and long‑term strategy.
Stock Performance
WELL HEALTH TECH (WHTCF) closed at $2.92 on October 8, 2026. Over the past 12 months, the price has lost 32.2%.
WHTCF Metrics & Rankings
Price returns through October 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
WELL HEALTH TECH has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, earnings date, offering. View all WHTCF news →
SEC Filings
Financial Highlights
Upcoming Events
Convertible debentures maturity
Series B redemption eligibility
Provincial EMR rollout target
Notes maturity
Senior Notes Maturity
WELL HEALTH TECH has 5 upcoming scheduled events. The next event, "Convertible debentures maturity", is scheduled for December 1, 2026 (in 51 days). 4 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the WHTCF stock price.
Short Interest History
Short interest in WELL HEALTH TECH (WHTCF) currently stands at 6.2 million shares, up 6.1% from the previous reporting period, representing 3.2% of the float. Since October 2025, short interest has increased by 77.8%.
Days to Cover History
Days to cover for WELL HEALTH TECH (WHTCF) currently stands at 199.6 days, up 149.1% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 269.3%. Across the settlements charted above, it has ranged from 34.3 to 199.6 days.
WHTCF Company Profile & Sector Positioning
WELL HEALTH TECH (WHTCF) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing WHTCF often look at related companies in the same sector, including AMER ONCOLOGY NETWORK A (AONC), HEALWELL AI INC A SUB VTG (HWAIF), HEALTHLYNKED CORP (HLYK), DRAEGERWERK AG (DGWPF), and KUROS BIOSCIENCE (CSBTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate WHTCF's relative position within its industry.